For citations:
FDA HAS APPROVED THE FIRST MEDICATION FOR RARE IMMUNITY-RELATED DISEASES. Pediatric pharmacology. 2024;21(3):296. (In Russ.)
FDA HAS APPROVED THE FIRST MEDICATION FOR RARE IMMUNITY-RELATED DISEASES. Pediatric pharmacology. 2024;21(3):296. (In Russ.)